Stay updated on Safety and Efficacy of Aflibercept in AMD Clinical Trial
Sign up to get notified when there's something new on the Safety and Efficacy of Aflibercept in AMD Clinical Trial page.

Latest updates to the Safety and Efficacy of Aflibercept in AMD Clinical Trial page
- Check2 days agoChange DetectedThe page footer now displays Revision: v3.6.4 instead of v3.6.3, indicating a new build of the ClinicalTrials.gov interface. This reflects an internal version update rather than changes to the study content or visible functionality.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check24 days agoChange DetectedThe page revision label was updated from v3.6.0 to v3.6.3, indicating a newer revision of the page. This change does not alter the study details or how to participate.SummaryDifference0.0%

- Check38 days agoChange DetectedRecruitment status is updated to no longer looking for participants, signaling that the study is not currently enrolling anyone. The page also adds new navigation/help sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the revision label to v3.6.0 while removing the previous v3.5.5 reference.SummaryDifference0.3%

- Check45 days agoChange DetectedThe page now displays a newer revision tag (v3.5.5) replacing the previous v3.5.4, indicating a backend or documentation update without altering the study details shown on the page.SummaryDifference0.0%

- Check66 days agoChange DetectedThe page revision label was updated from v3.5.3 to v3.5.4, indicating a new revision in the site's documentation/version history.SummaryDifference0.0%

- Check88 days agoChange DetectedThe page revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a site build change rather than an update to the study record content.SummaryDifference0.0%

Stay in the know with updates to Safety and Efficacy of Aflibercept in AMD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety and Efficacy of Aflibercept in AMD Clinical Trial page.